DF/Net Research visits Beijing Yurong

Lisa Ondrejcek and Darryl Pahl visited our new client in China, Beijing Yurong. We spent a full…

DF/Net Research enters into strategic CRO service partnership

DF/Net Research and ACE Research have entered into a strategic partnership to more comprehensively serve the global health drug development research efforts of academic, non-profit, and industry clients.

Edit Check Online Training: Available Now

One of DataFax's/DFdiscover’s most powerful components is the Edit Check language. Our training will prepare you to get the most out of the Edit Check language and bring your study to a whole new level.

Announcing DFdiscover 2018 Version 5.1.0

Available for immediate download, DFdiscover 2018 Version 5.1.0 follows the success of DFdiscover 2018. It includes several new features, including new subject scheduling, demonstration API implementations in DFweb and DFcollect, enhancements to existing features and improved look-and-feel.

DF/Net Research 15 Year Anniversary

Our president, Lisa Ondrejcek, shares her thoughts on the eve of DF/Net Research's 15 year anniversary.

Temperature-stable experimental tuberculosis vaccine enters clinical testing

Vaccinations have begun in a Phase 1 human clinical trial testing a freeze-dried, temperature-stable formulation of an experimental tuberculosis (TB) vaccine candidate. Continue reading on the National Institutes of Health website. DF/Net…

Inovio Presents Progression Free Survival & PSA Doubling Time Improvements in Prostate Cancer Patients Treated with INO-5150

Another exciting milestone for DF/Net client, Inovio Pharmaceuticals, Inc. Inovio Presents Progression Free Survival & PSA Doubling…

Immunotherapy targeting HPV 16/18 generates potent immune responses in HPV-Associated Head and Neck Cancer

More exciting news from DF/Net client, Inovio Pharmaceuticals, Inc. Major Cancer Journal Highlights Data From An Inovio-Sponsored Trial In Which A Patient Achieved Full Remission After Dosing With DNA Immunotherapy and Checkpoint…

HPTN 074 Demonstrates Significant Benefits Among People Living with HIV Who Inject Drugs

More terrific, breaking news from our friends at the HIV Prevention Trials Network. We've had the pleasure of providing data management support for the HPTN 074 trial since January 2015. Congratulations to…